Ensign Peak Advisors, Inc
- SEC CIK
- 0001454984
- Latest filing
- Aug 14, 2026
HRTX holding history
Heron Therapeutics, Inc. in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −175,572−100.0% | Sold out | Holders |
| Q3 2022 | 175,572 | $740.0K | <0.1% | +161,531+1,150.4% | Added | Holders |
| Q2 2022 | 14,041 | $39.0K | <0.1% | −21,539−60.5% | Reduced | Holders |
| Q1 2022 | 35,580 | $204.0K | <0.1% | −117,275−76.7% | Reduced | Holders |
| Q4 2021 | 152,855 | $1.40M | <0.1% | +29,740+24.2% | Added | Holders |
| Q3 2021 | 123,115 | $1.32M | <0.1% | +123,115 | New | Holders |